Moelis 将来の成長

NYSE:MC - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	1,548	256	N/A	N/A	7
12/31/2025	1,370	188	N/A	N/A	9
12/31/2024	1,095	77	N/A	N/A	9
9/30/2024	971	41	196	211	N/A
6/30/2024	969	13	197	214	N/A
3/31/2024	884	-12	125	146	N/A
12/31/2023	855	-25	142	158	N/A
9/30/2023	847	1	168	182	N/A
6/30/2023	808	37	157	167	N/A
3/31/2023	871	88	149	153	N/A
12/31/2022	985	150	27	33	N/A
9/30/2022	1,203	229	292	300	N/A
6/30/2022	1,460	324	481	490	N/A
3/31/2022	1,579	364	672	687	N/A
12/31/2021	1,541	365	921	937	N/A
9/30/2021	1,538	393	852	873	N/A
6/30/2021	1,254	305	629	658	N/A
3/31/2021	1,053	220	448	479	N/A
12/31/2020	943	179	389	429	N/A
9/30/2020	745	74	272	304	N/A
6/30/2020	769	81	239	263	N/A
3/31/2020	762	117	241	259	N/A
12/31/2019	747	105	203	209	N/A
9/30/2019	761	123	159	167	N/A
6/30/2019	737	115	262	270	N/A
3/31/2019	804	121	253	261	N/A
12/31/2018	886	141	384	391	N/A
9/30/2018	817	77	325	330	N/A
6/30/2018	779	63	N/A	231	N/A
3/31/2018	731	47	N/A	266	N/A
12/31/2017	685	29	N/A	233	N/A
9/30/2017	720	69	N/A	273	N/A
6/30/2017	701	60	N/A	290	N/A
3/31/2017	660	47	N/A	257	N/A
12/31/2016	613	38	N/A	232	N/A
9/30/2016	584	34	N/A	199	N/A
6/30/2016	585	35	N/A	185	N/A
3/31/2016	579	35	N/A	180	N/A
12/31/2015	552	33	N/A	143	N/A
9/30/2015	521	32	N/A	128	N/A
6/30/2015	498	28	N/A	138	N/A
3/31/2015	504	2	N/A	166	N/A
12/31/2014	519	-3	N/A	209	N/A
9/30/2014	529	21	N/A	241	N/A
6/30/2014	499	29	N/A	204	N/A
3/31/2014	466	70	N/A	156	N/A
12/31/2013	411	70	N/A	118	N/A

アナリストによる今後の成長予測

収入対貯蓄率: MCの予測収益成長率 (年間68.1% ) は貯蓄率 ( 2.6% ) を上回っています。

収益対市場: MCの収益 ( 68.1% ) はUS市場 ( 15.2% ) よりも速いペースで成長すると予測されています。

高成長収益: MCの収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: MCの収益 ( 20.4% ) US市場 ( 8.9% ) よりも速いペースで成長すると予測されています。

高い収益成長: MCの収益 ( 20.4% ) 20%よりも速いペースで成長すると予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: MCの自己資本利益率は、3年後には非常に高くなると予測されています ( 56.9 %)。

Moelis 将来の成長

Future 基準チェック /66

主要情報

今後の成長に関する最新情報

Price target decreased to US$37.00

Consensus EPS estimates fall by 17%

Price target decreased to US$39.83

Consensus EPS estimates fall by 24%

Price target decreased to US$46.57

Price target decreased to US$56.14

Recent updates

Moelis & Company Declares Regular Quarterly Dividend, Payable on December 2, 2024

Moelis: A Lot Still Riding On A Sponsor Recovery

Moelis & Company to Report Q3, 2024 Results on Oct 23, 2024

Moelis & Company Declares Regular Quarterly Dividend, Payable on September 26, 2024

Moelis & Company to Report Q2, 2024 Results on Jul 24, 2024

Moelis & Company(NYSE:MC) dropped from Russell 3000 Value Index

Moelis: Sponsors Still On Sidelines

Moelis & Company, Annual General Meeting, Jun 06, 2024

Moelis & Company Declares Regular Quarterly Dividend, Payable on June 20, 2024

Moelis & Company to Report Q1, 2024 Results on Apr 24, 2024

Moelis & Company Declares Regular Quarterly Dividend, Payable on March 28, 2024

Moelis: Restructuring One-Offs Surge Revenues

Moelis & Company to Report Q4, 2023 Results on Feb 07, 2024

Moelis & Company: Solid Company, But A Rich Valuation

Moelis & Company Declares Regular Quarterly Dividend, Payable on December 22, 2023

Moelis & Company to Report Q3, 2023 Results on Nov 02, 2023

Moelis: The Time Has Come For M&A

Moelis & Company Appoints Arash Nazhad as A Managing Director

Moelis & Company Declares Regular Quarterly Dividend, Payable on September 22, 2023

Moelis: Deteriorating Financials And Further Downside Ahead

Moelis & Company to Report Q2, 2023 Results on Jul 26, 2023

Moelis & Company Promotes Olena Sokolowska and Kartik Sudeep to Managing Director

Moelis Q4 2022 Earnings Preview

Moelis & Company to Report Q4, 2022 Results on Feb 08, 2023

Moelis: Hit Hardest By M&A Stop, Has The Most To Gain On Certainty

Genesis Global Trading Inc. May File for Bankruptcy

Moelis & Company Appoints Laila J. Worrell to its Board of Directors, Effective January 1, 2023

Now 22% undervalued

Founder recently sold US$9.0m worth of stock

Now 21% undervalued after recent price drop

Insufficient new directors

Vice Chairman & MD exercised options and sold US$50k worth of stock

Third quarter 2022 earnings: Revenues exceed analyst expectations

Moelis & Company Declares Regular Quarterly Dividend, Payable on December 2, 2022

Moelis Is Feeling The Sting Of Falling Sponsor Activity

Price target decreased to US$37.00

Consensus EPS estimates fall by 17%

Moelis & Company to Report Q3, 2022 Results on Nov 02, 2022

Price target decreased to US$39.83

Moelis & Company: Dividend King To Hold Until Next Economic Cycle

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Moelis & Company Declares Quarterly Dividend, Payable on August 23, 2022

Moelis Q2 2022 Earnings Preview

Bearish: Analysts Just Cut Their Moelis & Company (NYSE:MC) Revenue and EPS estimates

Consensus EPS estimates fall by 24%

Price target decreased to US$46.57

Moelis & Company to Report Q2, 2022 Results on Jul 27, 2022

Moelis stock edges down after UBS points to weaker M&A pipeline

Investor sentiment deteriorated over the past week

Founding Partner recently sold US$317k worth of stock

Moelis Manages To Sustain M&A-Based Growth

Vice Chairman & MD exercised options and sold US$215k worth of stock

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Moelis & Company Declares Quarterly Dividend, Payable on June 8, 2022

Insufficient new directors

Moelis & Company, Annual General Meeting, Jun 02, 2022

With EPS Growth And More, Moelis (NYSE:MC) Is Interesting

Moelis & Company to Report Q1, 2022 Results on Apr 27, 2022

Price target decreased to US$56.14

Moelis & Co: M&A Pace Is Slowing Down, At Least They Have Restructuring

Chief Compliance Officer recently sold US$364k worth of stock

Co-Founder exercised options and sold US$3.0m worth of stock

Vice Chairman & MD exercised options and sold US$72k worth of stock

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Moelis & Company Declares Regular Quarterly Dividend, Payable on March 28, 2022

Insufficient new directors

Is Now The Time To Put Moelis (NYSE:MC) On Your Watchlist?

Moelis: Undervalued Stock With Strong Organic Growth And 7+% Dividend Yield

Price target increased to US$76.43